Shareholders' equity · 2013–2025
Axsome Therapeutics shareholders' equity
$88.3M+54.9% · FY2025
Axsome Therapeutics (AXSM) reported $88.3M in shareholders' equity for fiscal 2025, +54.9% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $88.3M | +54.9% | Open → |
| FY20242024-12-31 | $57.0M | −70.1% | Open → |
| FY20232023-12-31 | $191M | +74.3% | Open → |
| FY20222022-12-31 | $110M | +600.9% | Open → |
| FY20212021-12-31 | $15.6M | −86.3% | Open → |
| FY20202020-12-31 | $114M | −36.3% | Open → |
| FY20192019-12-31 | $179M | +18,955.2% | Open → |
| FY20182018-12-31 | $937,921 | −94.4% | Open → |
| FY20172017-12-31 | $16.7M | −22.5% | Open → |
| FY20162016-12-31 | $21.6M | −53.6% | Open → |
| FY20152015-12-31 | $46.4M | +$49.6M | Open → |
| FY20142014-12-31 | −$3.2M | −$1.2M | Open → |
| FY20132013-12-31 | −$2.0M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Axsome Therapeutics shareholders' equity |url=https://companiesranked.com/en/company/axsome-therapeutics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Axsome Therapeutics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/axsome-therapeutics/shareholders-equityBibTeX
@misc{companiesranked-en-company-axsome-therapeutics-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Axsome Therapeutics shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/axsome-therapeutics/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-342360 · August 10, 2026
{{cite web |title=Axsome Therapeutics shareholders' equity — 10-Q (0001193125-26-342360) |url=https://www.sec.gov/Archives/edgar/data/1579428/000119312526342360/axsm-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.